Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
BACKGROUND: Advanced liver fibrosis is the most important prognostic factor in nonalcoholic fatty liver disease (NAFLD). The long noncoding RNA (lncRNA), growth arrest-specific transcript 5 (GAS5), is associated with the inhibition of liver fibrogenesis, and its levels are decreased in cirrhotic liver.
METHODS: We analyzed 51 patients with NAFLD, the diagnosis of which was confirmed by liver biopsy. Expression of GAS5 in both the liver and plasma of the patients was analyzed using a quantitative real-time polymerase chain reaction according to the fibrosis stage.
RESULTS: Plasma GAS5 expression was significantly higher in patients with advanced fibrosis than in those without. As the fibrosis progressed, GAS5 expression in plasma increased, with the exception of that in cirrhotic livers. Plasma levels of GAS5 were lower in patients with cirrhosis than in those with advanced fibrosis.
CONCLUSION: Elevated circulating levels of the lncRNA GAS5 are associated with the progression of liver fibrosis prior to the development of cirrhosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Genes - 11(2020), 5 vom: 13. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Han, Man-Hoon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarker |
|---|
| Anmerkungen: |
Date Completed 24.03.2021 Date Revised 24.03.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/genes11050545 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309966752 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309966752 | ||
| 003 | DE-627 | ||
| 005 | 20231226201433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/genes11050545 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM309966752 | ||
| 035 | |a (NLM)32413995 | ||
| 035 | |a (PII)E545 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Han, Man-Hoon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2021 | ||
| 500 | |a Date Revised 24.03.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Advanced liver fibrosis is the most important prognostic factor in nonalcoholic fatty liver disease (NAFLD). The long noncoding RNA (lncRNA), growth arrest-specific transcript 5 (GAS5), is associated with the inhibition of liver fibrogenesis, and its levels are decreased in cirrhotic liver | ||
| 520 | |a METHODS: We analyzed 51 patients with NAFLD, the diagnosis of which was confirmed by liver biopsy. Expression of GAS5 in both the liver and plasma of the patients was analyzed using a quantitative real-time polymerase chain reaction according to the fibrosis stage | ||
| 520 | |a RESULTS: Plasma GAS5 expression was significantly higher in patients with advanced fibrosis than in those without. As the fibrosis progressed, GAS5 expression in plasma increased, with the exception of that in cirrhotic livers. Plasma levels of GAS5 were lower in patients with cirrhosis than in those with advanced fibrosis | ||
| 520 | |a CONCLUSION: Elevated circulating levels of the lncRNA GAS5 are associated with the progression of liver fibrosis prior to the development of cirrhosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a liver fibrosis | |
| 650 | 4 | |a lncRNA GAS5 | |
| 650 | 4 | |a nonalcoholic fatty liver disease | |
| 650 | 4 | |a noncoding RNA | |
| 650 | 7 | |a GAS5 long non-coding RNA, human |2 NLM | |
| 650 | 7 | |a RNA, Long Noncoding |2 NLM | |
| 700 | 1 | |a Lee, Jee Hyun |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Gyeonghwa |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Eunhye |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Yu Rim |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Se Young |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hye Won |e verfasserin |4 aut | |
| 700 | 1 | |a Chun, Jae Min |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Young Seok |e verfasserin |4 aut | |
| 700 | 1 | |a Yoon, Jun Sik |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Min Kyu |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Won Kee |e verfasserin |4 aut | |
| 700 | 1 | |a Kweon, Young Oh |e verfasserin |4 aut | |
| 700 | 1 | |a Tak, Won Young |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Soo Young |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Jung Gil |e verfasserin |4 aut | |
| 700 | 1 | |a Hur, Keun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genes |d 2011 |g 11(2020), 5 vom: 13. Mai |w (DE-627)NLM220446326 |x 2073-4425 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g number:5 |g day:13 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/genes11050545 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |e 5 |b 13 |c 05 | ||